Apalutamide will reduce the extent or effect of ethinylestradiol by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Stay away from or Use Alternate Drug. Coadministration of apalutamide, a powerful CYP3A4 inducer, with prescription drugs which have been CYP3A4 substrates may lead to decrease exposure to those prescription drugs. Females who at this https://eugenek594fyq4.fliplife-wiki.com/user